FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1903533038> ?p ?o ?g. }

• W1903533038 endingPage "1912" @default.
• W1903533038 startingPage "1907" @default.
• W1903533038 abstract "An early phase II study of a new camptothecin analog and an inhibitor of topoisomerase I, CPT-11, was conducted in 62 patients with refractory leukemia and lymphoma by four different treatment schedules in a multiinstitutional cooperative study. CPT-11 therapy resulted in four complete remissions (CRs) and three partial remissions (PRs) in 29 assessable non-Hodgkin's lymphoma (NHL) patients, one PR in three Hodgkin's disease (HD), one CR and one PR in 11 acute lymphoblastic leukemia (ALL), and one PR in 15 acute myelogenous leukemia (AML) patients. Single infusion of 200 mg/m2 every 3 to 4 weeks produced no response in both leukemia and lymphoma patients. Sixty-minute infusions of 40 mg/m2/d for 5 days every 3 to 4 weeks or for 3 days weekly produced four CRs (17%) and four PRs (17%) in 24 patients with malignant lymphoma. Sixty-minute infusions of 20 mg/m2 twice a day for 7 days every 3 to 4 weeks resulted in one CR and two PRs in 12 patients with acute leukemia. No response was seen in an acute leukemia patient by another treatment schedule. CPT-11 was effective in two (15%) of 13 primarily refractory leukemia and lymphoma cases, in two of four relapsed cases, and in seven (17%) of 41 relapsed and refractory cases. Major side effects were leukopenia (91%) and gastrointestinal (GI) (76%). CPT-11 was shown to be effective against refractory leukemia and lymphoma, and thus deserves further clinical study; the novel antitumor activity mode of this drug predicts no cross-resistance to presently available antitumor drugs." @default.
• W1903533038 created "2016-06-24" @default.
• W1903533038 creator A5005416105 @default.
• W1903533038 creator A5012331457 @default.
• W1903533038 creator A5012352553 @default.
• W1903533038 creator A5014133673 @default.
• W1903533038 creator A5025918126 @default.
• W1903533038 creator A5043473173 @default.
• W1903533038 creator A5054913417 @default.
• W1903533038 creator A5063488239 @default.
• W1903533038 creator A5066355351 @default.
• W1903533038 creator A5080343888 @default.
• W1903533038 date "1990-11-01" @default.
• W1903533038 modified "2023-09-27" @default.
• W1903533038 title "An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma." @default.
• W1903533038 cites W1536538430 @default.
• W1903533038 cites W1567663060 @default.
• W1903533038 cites W1973057627 @default.
• W1903533038 cites W2001096578 @default.
• W1903533038 cites W2016254453 @default.
• W1903533038 cites W2018185888 @default.
• W1903533038 cites W2028269517 @default.
• W1903533038 cites W2078751203 @default.
• W1903533038 cites W2112902082 @default.
• W1903533038 cites W2125397490 @default.
• W1903533038 cites W2137814084 @default.
• W1903533038 cites W2409210411 @default.
• W1903533038 cites W2409646217 @default.
• W1903533038 cites W2413694431 @default.
• W1903533038 cites W2419655738 @default.
• W1903533038 cites W2429945373 @default.
• W1903533038 cites W37120966 @default.
• W1903533038 doi "https://doi.org/10.1200/jco.1990.8.11.1907" @default.
• W1903533038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2230878" @default.
• W1903533038 hasPublicationYear "1990" @default.
• W1903533038 type Work @default.
• W1903533038 sameAs 1903533038 @default.
• W1903533038 citedByCount "221" @default.
• W1903533038 countsByYear W19035330382012 @default.
• W1903533038 countsByYear W19035330382013 @default.
• W1903533038 countsByYear W19035330382015 @default.
• W1903533038 countsByYear W19035330382016 @default.
• W1903533038 countsByYear W19035330382020 @default.
• W1903533038 countsByYear W19035330382021 @default.
• W1903533038 countsByYear W19035330382022 @default.
• W1903533038 countsByYear W19035330382023 @default.
• W1903533038 crossrefType "journal-article" @default.
• W1903533038 hasAuthorship W1903533038A5005416105 @default.
• W1903533038 hasAuthorship W1903533038A5012331457 @default.
• W1903533038 hasAuthorship W1903533038A5012352553 @default.
• W1903533038 hasAuthorship W1903533038A5014133673 @default.
• W1903533038 hasAuthorship W1903533038A5025918126 @default.
• W1903533038 hasAuthorship W1903533038A5043473173 @default.
• W1903533038 hasAuthorship W1903533038A5054913417 @default.
• W1903533038 hasAuthorship W1903533038A5063488239 @default.
• W1903533038 hasAuthorship W1903533038A5066355351 @default.
• W1903533038 hasAuthorship W1903533038A5080343888 @default.
• W1903533038 hasConcept C121332964 @default.
• W1903533038 hasConcept C126322002 @default.
• W1903533038 hasConcept C142424586 @default.
• W1903533038 hasConcept C178790620 @default.
• W1903533038 hasConcept C185592680 @default.
• W1903533038 hasConcept C2776694085 @default.
• W1903533038 hasConcept C2776863199 @default.
• W1903533038 hasConcept C2778041864 @default.
• W1903533038 hasConcept C2778461978 @default.
• W1903533038 hasConcept C2779338263 @default.
• W1903533038 hasConcept C2779682216 @default.
• W1903533038 hasConcept C71924100 @default.
• W1903533038 hasConcept C87355193 @default.
• W1903533038 hasConcept C90924648 @default.
• W1903533038 hasConceptScore W1903533038C121332964 @default.
• W1903533038 hasConceptScore W1903533038C126322002 @default.
• W1903533038 hasConceptScore W1903533038C142424586 @default.
• W1903533038 hasConceptScore W1903533038C178790620 @default.
• W1903533038 hasConceptScore W1903533038C185592680 @default.
• W1903533038 hasConceptScore W1903533038C2776694085 @default.
• W1903533038 hasConceptScore W1903533038C2776863199 @default.
• W1903533038 hasConceptScore W1903533038C2778041864 @default.
• W1903533038 hasConceptScore W1903533038C2778461978 @default.
• W1903533038 hasConceptScore W1903533038C2779338263 @default.
• W1903533038 hasConceptScore W1903533038C2779682216 @default.
• W1903533038 hasConceptScore W1903533038C71924100 @default.
• W1903533038 hasConceptScore W1903533038C87355193 @default.
• W1903533038 hasConceptScore W1903533038C90924648 @default.
• W1903533038 hasIssue "11" @default.
• W1903533038 hasLocation W19035330381 @default.
• W1903533038 hasLocation W19035330382 @default.
• W1903533038 hasOpenAccess W1903533038 @default.
• W1903533038 hasPrimaryLocation W19035330381 @default.
• W1903533038 hasRelatedWork W1583871986 @default.
• W1903533038 hasRelatedWork W1903533038 @default.
• W1903533038 hasRelatedWork W1966551433 @default.
• W1903533038 hasRelatedWork W2073730465 @default.
• W1903533038 hasRelatedWork W2349679547 @default.
• W1903533038 hasRelatedWork W2358739720 @default.
• W1903533038 hasRelatedWork W2360827738 @default.
• W1903533038 hasRelatedWork W2396499999 @default.

• next